☰

John A. Jakob, Ph.D. - Publications

Affiliations: 
2004 Columbia University, New York, NY 
Area:
Genetics, Oncology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, Brown PD, Davies MA, Sulman EP. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. Journal of Neuro-Oncology. PMID 29198052 DOI: 10.1007/S11060-017-2695-2  0.44
2015 Jakob JA, Kies MS, Glisson BS, Kupferman ME, Liu DD, Lee JJ, El-Naggar AK, Gonzalez-Angulo AM, Blumenschein GR. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head & Neck. 37: 644-9. PMID 24585506 DOI: 10.1002/Hed.23647  0.347
2013 Bucheit AD, Syklawer E, Jakob JA, Bassett RL, Curry JL, Gershenwald JE, Kim KB, Hwu P, Lazar AJ, Davies MA. Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma. Cancer. 119: 3821-9. PMID 23922205 DOI: 10.1002/Cncr.28306  0.472
2013 Stockman D, Tetzlaff MT, Al-Zaid T, Torres-Cabala CA, Bucheit AD, Lazar AJF, Sui D, Jakob JA, Bassett R, Prieto VG, Davies MA, Curry JL. Differential clinical associations of BRAF and NRAS mutations among histologic types of cutaneous melanomas. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E20034  0.433
2012 Jakob JA, Bassett RL, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer. 118: 4014-23. PMID 22180178 DOI: 10.1002/Cncr.26724  0.438
2012 Koay EJ, Bucheit AD, Jakob JA, Hyun ED, Settle SH, Brown PD, Davies MA, Sulman EP. Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. Journal of Clinical Oncology. 30: 8584-8584. DOI: 10.1200/Jco.2012.30.15_Suppl.8584  0.44
2011 Jakob JA, Bassett RL, Ng CS, Lazar AJ, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Hwu P, Kim KB, Davies MA. Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8500. PMID 28021153 DOI: 10.1200/Jco.2011.29.15_Suppl.8500  0.444
2005 Jakob J, Nagase S, Gazdar A, Chien M, Morozova I, Russo JJ, Nandula SV, Murty VV, Li CM, Tycko B, Parsons R. Two somatic biallelic lesions within and near SMAD4 in a human breast cancer cell line. Genes, Chromosomes & Cancer. 42: 372-83. PMID 15645498 DOI: 10.1002/Gcc.20142  0.369
Show low-probability matches.